ID: ALA3613779

Max Phase: Preclinical

Molecular Formula: C16H16N2O4S

Molecular Weight: 332.38

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NS(=O)(=O)c1ccc(C(=O)N2CCc3cc(O)ccc3C2)cc1

Standard InChI:  InChI=1S/C16H16N2O4S/c17-23(21,22)15-5-2-11(3-6-15)16(20)18-8-7-12-9-14(19)4-1-13(12)10-18/h1-6,9,19H,7-8,10H2,(H2,17,21,22)

Standard InChI Key:  VUKZKNAWALGCHU-UHFFFAOYSA-N

Associated Targets(Human)

Carbonic anhydrase XIV 1305 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Carbonic anhydrase IX 8255 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Carbonic anhydrase VII 2318 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Carbonic anhydrase II 17698 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Carbonic anhydrase I 13240 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 332.38Molecular Weight (Monoisotopic): 332.0831AlogP: 1.24#Rotatable Bonds: 2
Polar Surface Area: 100.70Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.30CX Basic pKa: CX LogP: 1.34CX LogD: 1.33
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.86Np Likeness Score: -1.17

References

1. Buemi MR, De Luca L, Ferro S, Bruno E, Ceruso M, Supuran CT, Pospíšilová K, Brynda J, Řezáčová P, Gitto R..  (2015)  Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms.,  102  [PMID:26276436] [10.1016/j.ejmech.2015.07.049]

Source